Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.
Metab Syndr Relat Disord. 2012 Aug;10(4):252-9. doi: 10.1089/met.2011.0117. Epub 2012 Mar 2.
Classification schema such as metabolic syndrome may underestimate cardiovascular disease (CVD) risk in African Americans, despite a higher burden of CVD in African Americans. Oxidative stress results from an imbalance of prooxidants and antioxidants and leads to endothelial dysfunction that promotes vascular inflammation and atherosclerosis. Aminothiol markers of oxidative stress are associated with CVD risk factors and metabolic syndrome; however, little is known about racial differences in levels of oxidative stress. We sought to investigate whether oxidative stress would be higher in African Americans compared to whites independently of traditional risk factor burden.
We assessed oxidative stress in a biracial, community-based cohort. In 620 subjects (59% female, 52% African American) in the Morehouse and Emory Team up to Eliminate Health Disparities (META-Health) study, we measured plasma levels of glutathione, an intracellular antioxidant, and its redox potential as a ratio of reduced and oxidized glutathione (E(h) glutathione).
African Americans had lower glutathione levels (P<0.001) compared to whites. There was a trend toward more oxidized E(h) glutathione (P = 0.07) in African Americans; however, this did not reach statistical significance. After adjustment for demographics and CVD risk factors, African-American race remained a significant correlate of lower glutathione levels (P<0.001) and a more oxidized E(h) glutathione (P = 0.04). After further adjustment for high-sensitivity C-reactive protein (hsCRP), glutathione remained significantly lower in African Americans (P = 0.001). African Americans with or without metabolic syndrome had lower glutathione levels compared to whites with or without metabolic syndrome, respectively (both P ≤ 0.001), and African Americans without metabolic syndrome had a more oxidized E(h) glutathione compared to whites without metabolic syndrome (P = 0.003).
African Americans have higher levels of oxidative stress than whites, even after adjustment for differences in CVD risk factors and inflammation. Racial differences in oxidative stress may play a key role in understanding observed racial disparities in CVD.
代谢综合征等分类方案可能会低估非裔美国人的心血管疾病 (CVD) 风险,尽管非裔美国人 CVD 的负担更高。氧化应激是由促氧化剂和抗氧化剂之间的不平衡引起的,导致内皮功能障碍,从而促进血管炎症和动脉粥样硬化。氧化应激的氨基硫醇标志物与 CVD 危险因素和代谢综合征相关;然而,关于氧化应激的种族差异知之甚少。我们试图研究氧化应激是否会在非裔美国人中高于白人,而与传统的危险因素负担无关。
我们在一个以社区为基础的、由多种族组成的队列中评估了氧化应激。在莫尔豪斯和埃默里团队消除健康差异研究(META-Health 研究)中的 620 名受试者(59%为女性,52%为非裔美国人)中,我们测量了血浆中谷胱甘肽(一种细胞内抗氧化剂)的水平及其还原型和氧化型谷胱甘肽的氧化还原电势比(E(h) 谷胱甘肽)。
与白人相比,非裔美国人的谷胱甘肽水平较低(P<0.001)。非裔美国人的 E(h) 谷胱甘肽更倾向于氧化(P = 0.07);然而,这并没有达到统计学意义。在调整了人口统计学和 CVD 危险因素后,非裔美国人的种族仍然是谷胱甘肽水平较低(P<0.001)和 E(h) 谷胱甘肽更氧化(P = 0.04)的显著相关因素。在进一步调整了高敏 C 反应蛋白(hsCRP)后,非裔美国人的谷胱甘肽水平仍然显著低于白人(P = 0.001)。非裔美国人无论是否患有代谢综合征,其谷胱甘肽水平均低于白人,无论是否患有代谢综合征(均 P ≤ 0.001),非裔美国人中没有代谢综合征的人 E(h) 谷胱甘肽比没有代谢综合征的白人更氧化(P = 0.003)。
即使在调整了 CVD 危险因素和炎症的差异后,非裔美国人的氧化应激水平也高于白人。氧化应激的种族差异可能在理解观察到的 CVD 种族差异方面发挥关键作用。